Clinical application of advanced neuroimaging techniques – Magnetic Resonance Spectroscopy
DOI:
https://doi.org/10.15584/ejcem.2017.2.6Keywords:
spectroscopy, MR, SVS, CSIAbstract
Continuous scientific research and the increasing saturation of the medical market in Poland implements the possibilities of using advanced MR techniques including MRS in everyday practice. This method, which has so far been used primarily for research purposes, can bring measurable benefits to patients not only in terms of clarifying diagnosis and narrowing differential diagnosis, but also monitoring the course of various diseases and their treatment. Here we present the basic principles of performing and interpreting spectroscopic spectra and possible clinical applications and development prospects of MRS. The literature reviewed both Polish and foreign articles both historically and in the past 10 years. The paper presents methodological issues related to the proper performance of magnetic resonance spectroscopy (MRS) and spectral composition and the role of major metabolites, as well as current clinical applications and directions of MRS development.Downloads
References
Bertoldo D, Watcharakorn A, Castillo M. Brain proton magnetic resonance spectroscopy. Introduction and overview. Neuroimag Clin N Am. 2013;23:359-380.
Jansen JFA, Backes WH, Nicolay K, Kooi ME. 1H MR spectroscopy of the brain : absolute quantification of metabolites. Radiology. 2006;240:318-332.
Posse S, Otazo R, Dager SR, Alger J. MR spectroscopis imaging : principles and recent advances. J Magn Reson Imaging. 2013;37:1301-1325.
Moonen CT, von Kienlinvan M, van Zijl PC, et al. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed. 1989;2:201-207.
Maudsley AA, Darkazanli A, Alger JR, et al. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed. 2006;19:492-503.
Klose U. Measurement sequences for single proton MR scpectroscopy. Eur J Radiol. 2008;67: 194-201.
Inverse problems. http://lcmodel.ca. Updated Novemver 18, 2016.
Sobiecka B, Urbanik A. The role of choline (Cho) in the diagnostics and differentiation of brain tumours with H MRS technique. Pol J Radiol. 2009;74:7.
Oz G, Alger R, Barker PB, et al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology. 2014;270:658-679.
Herminghaus S, Dierks T, Pilatus U, et al. Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. Journal of Neurosurgery. 2003;1:74-81.
Julià-Sapé M, Griffiths JR, Tate RA. Classification of brain tumours from MR spectra: the INTERPRET collaboration and its outcomes. NMR in Biomedicine. 2015(28):12,1772-1787.
Jaskólski DJ, Fortuniak J, Majos A et al. Magnetic resonance spectroscopy in intracranial tumours of glial origin. Neurol Neurochir Pol. 2013;47(5):438-449.
Jaskólski DJ, Fortuniak J, Stefańczyk L, Majos A, et al. Differential diagnosis of intracranial meningiomas based on magnetic resonance spectroscopy. Neurol Neurochir Pol. 2013;47(3):247-255.
An academic search engine for scientific articles site. https://pdfs.semanticscholar.org. Updated February 20, 2016.
Magierski R, Sobów T, Kłoszewska I. Spektroskopia MR w chorobach zwyrodnieniowych ośrodkowego układu nerwowego. Postępy Psychiatrii i Neurologii. 2005;14(2):155-163.
Urbanik A. Diagnostyka otępienia przy pomocy protonowej spektroskopii MR. Przegl Lek. 2010;67:237.
Szafirska M, Urbanik A, Róg T. Zmiany metaboliczne w obrębie blaszek u chorych na stwardnienie rozsiane - ocena w technice protonowej spektroskopii MR (1HMRS). Prz Lek. 2013;70(5):328-334.
Szafirska M, Urbanik A. Rola rezonansu magnetycznego w diagnostyce stwardnienia rozsianego. Ogólnopol Prz Med. 2012;3:48-53.
Podsiadło L, Urbanik A, Garlicki A, et al. 1H MRS application in the evaluation of CNS in the patents with AIDS. Pol J Radiol. 2003;68(3):5-9.
Michalska J, Kociemba W, Steinborn B, et al. Rola spektroskopii rezonansu magnetycznego w padaczce. Neur Dziecięca, 2008;34:61-64.
Silverstone PH, McGrath BM, Kim H. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disord. 2005;7(1):1-10.
Renshow PF, Lafer B, Babb SM, et al. Basal ganglia choline levels in depression and response due to fluoxetine treatment: in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 1997;41(8):837-43.
Rachel W, Siwek M, Dudek D, et al. Protonowa spektroskopia rezonansu magnetycznego w zaburzeniach afektywnych. Neuropsychiatr Neuropsychol. 2008;3:29.
Herman-Sucharska I, Werewka-Maczuga A, Urbanik A, et al. Ocena przydatności protonowej spektroskopii MR w diagnostyce i monitorowaniu leczenia choroby afektywnej jednobiegunowej. Przegl Lek. 2010;67:4.
Karcz P, Urbanik A. Spektroskopia protonowa mięśni podudzia przed i po wysiłku fizycznym. Przegl Lek. 2013;70(5):286-92.
Zaleska T, Walecki J, Michalak M, Michalak E. Spektroskopia magnetycznego rezonansu w kardiologii. Medical Science Review- Diagnostyka Obrazowa. 2002;1:20-24.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 European Journal of Clinical and Experimental Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.




